Abstract BACKGROUND Circulating tumor DNA (ctDNA) has emerged as a good candidate
for tracking tumor dynamics in different cancer types, potentially avoiding repeated tumor …

Worldwide, colorectal cancer (CRC) is a deadly disease whose death rate ranks second
among cancers though its incidence ranks third. Early CRC detection is key and is …

Solid tumors shed DNA into circulation, and there is growing evidence that the detection of
circulating tumor DNA (ctDNA) has broad clinical utility, including monitoring of disease …

Circulating tumor DNA (ctDNA) has emerged as a useful diagnostic and prognostic
biomarker in many cancers. Here, we conducted a study to investigate the potential use of …

Abstract Background Circulating tumor DNA (ctDNA) is a promising diagnostic and
prognostic marker for many cancers and has been actively investigated in recent years …

Importance Detection of molecular residual disease and risk stratification as early as
possible may improve the treatment of patients with cancer. Efficient pragmatic tests are …

Background: ctDNA has the potential to identify patients (pts) with early stage cancer;
however, current assays are challenged by limited sensitivity (~ 50%), reliance on a single …

Background Cell-free circulating tumour-derived DNA (ctDNA) can be detected by testing for
methylated BCAT1 and IKZF1 DNA, which has proven sensitivity for colorectal cancer …

Simple Summary Malignant liver tumors consist of primary tumors and metastases. A correct
diagnosis can be achieved with different methods; one of them is the analysis of the cell-free …

Background: The early identification of treatment effect is wanted in several settings,
including the management of metastatic colorectal cancer (mCRC). A potential universal …